Pulmonary Medicine

Episodes 1-11 of 11

• • 

    

    Paul Paik, MD

    Peer

  • 

    

    Joshua K. Sabari, MD

    Peer

  3

  

  RestartResume

  Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC

  RestartResume

  Meeting Future Global Challenges: Case-Based Presentations in the Management of NSCLC

  0.25 credits

  Meeting Future Global Challenges: Case-Based Presentations in the Management ...

  0.25 credits

• • 

    

    Paul Paik, MD

    Peer

  • 

    

    Viola Zhu, MD

    Peer

  1

  

  RestartResume

  Therapy Gaps: Identifying New Targets in the Management of NSCLC

  RestartResume

  Therapy Gaps: Identifying New Targets in the Management of NSCLC

  0.25 credits

  Therapy Gaps: Identifying New Targets in the Management of NSCLC

  0.25 credits

• • 

    

    Paul Paik, MD

    Peer

  • 

    

    Jyoti D. Patel, MD, FASCO

    Peer

  5

  

  RestartResume

  Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations

  RestartResume

  Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrations

  0.25 credits

  Liquid and Tissue Biopsy in the Treatment of NSCLC: Focus on MET Gene Aberrat...

  0.25 credits

• • 

    

    Brendan J. Canning, PhD

    Peer

  • 

    

    Peter Dicpinigaitis, MD

    Peer

  1

  

  0.25 credits

  Diagnosis and Management of Unexplained or Refractory
  Chronic Cough

  0.25 credits

• • 

    

    Brendan J. Canning, PhD

    Peer

  • 

    

    Peter Dicpinigaitis, MD

    Peer

  9

  

  RestartResume

  Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough

  RestartResume

  Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic Cough

  0.25 credits

  Opening a New Chapter on the Diagnosis and Management of Unexplained Chronic ...

  0.25 credits

• • 

    

    Peter Dicpinigaitis, MD

    Peer

  • 

    

    Brendan J. Canning, PhD

    Peer

  9

  

  RestartResume

  Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto Itself

  RestartResume

  Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto Itself

  0.25 credits

  Unexplained Chronic Cough—Not Just a Disease Symptom, but a Condition unto It...

  0.25 credits

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Gregory S. Sawicki, MD, MPH

    Peer

  5

  

  RestartResume

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  RestartResume

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  0.25 credits

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  0.25 credits

• • 

    

    Angel O. Coz Yataco, MD, FCCP

    Peer

  • 

    

    Julio A. Ramírez, MD, FACP

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  1

  

  RestartResume

  Ciencia Emergente en Pacientes de Alto Riesgo: Selección Apropiada de Terapia Antiviral Contra la Influenza

  RestartResume

  Ciencia Emergente en Pacientes de Alto Riesgo: Selección Apropiada de Terapia Antiviral Contra la Influenza

  0.25 credits

  Ciencia Emergente en Pacientes de Alto Riesgo: Selección Apropiada de Terapia...

  0.25 credits

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Alexander Drilon, MD

    Peer

  11

  

  RestartResume

  Keeping Pace: Advances in RET Fusion-Positive NSCLC

  RestartResume

  Keeping Pace: Advances in RET Fusion-Positive NSCLC

  0.25 credits

  Keeping Pace: Advances in RET Fusion-Positive NSCLC

  0.25 credits

• • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Helena Yu, MD

    Peer

  9

  

  RestartResume

  Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC

  RestartResume

  Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC

  0.25 credits

  Keeping Pace: Advances in First-Line Therapy for EGFR-mutated NSCLC

  0.25 credits

• • 

    

    Julio A. Ramírez, MD, FACP

    Peer

  • 

    

    Charles P. Vega, MD

    Peer

  4

  

  RestartResume

  Selección Apropiada de Terapia Antiviral Contra la Influenza

  RestartResume

  Selección Apropiada de Terapia Antiviral Contra la Influenza

  0.25 credits

  Selección Apropiada de Terapia Antiviral Contra la Influenza

  0.25 credits